文献速递药物不良反应与药物警戒

挪威药物警戒人员使用MedDRA编码模糊信息时的策略与挑战

Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers.
PubMed 文献 · Drug Saf · 2025-07-01

本研究通过问卷调查和焦点小组访谈,探讨挪威药物警戒人员对模糊不良事件进行MedDRA编码时的推理与策略,并分类编码不一致类型。26名编码员完成11项编码任务,仅36%答案与标准术语选择一致,最常见不一致为替换术语(30%)。焦点小组揭示翻译困难、模糊消解策略等根源,呼吁针对性培训和机构指南。

要点

  • 仅36%的编码答案与标准术语选择一致,不一致程度因任务而异。
  • 最常见不一致为替换术语(30%),其次为遗漏(18%)和添加(6%)。
  • 翻译困难、模糊消解策略和因果推理是编码不一致的主要来源。

核心结论

  • 药物警戒人员使用MedDRA编码模糊不良事件时存在显著不一致,需针对性培训和机构指南。

研究设计与样本

  • 基于问卷调查的横断面研究,后接焦点小组访谈,26名挪威公共卫生部门药物警戒人员参与。

主要发现

  • 36%的问卷答案与标准术语选择一致,一致性因任务而异且与感知难度无关。
  • 30%的答案存在替换不一致,18%存在遗漏无替换,6%添加了不必要术语。
  • 焦点小组揭示替换源于翻译困难和模糊消解策略,遗漏源于语境思维和因果推理等。

关键数值与推荐

  • 标准术语选择由作者与MedDRA培训师协商确定。
  • 难度分级采用1(最不难)至4(最难)量表。
  • 不一致分类为遗漏、替换和添加。

临床怎么用

  • 建议开展针对性培训项目,并制定清晰的机构编码指南以减少不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Medical Dictionary for Regulatory Activities (MedDRA®) is an international standardized medical terminology used to code various types of medical information, including safety reports of suspected adverse reactions to medicines. Quantitative studies have highlighted varying levels of coding inconsistency across MedDRA®-relevant platforms, though the possible grounds of such inconsistency remain unclear. OBJECTIVE: We explored the reasoning and strategies employed by pharmacovigilance officers when coding selected ambiguous adverse events to MedDRA®, categorized the types of coding inconsistencies, and explored sources of the inconsistencies. METHODS: Pharmacovigilance officers from the Norwegian public health sector were invited to participate in a survey-based, cross-sectional study followed by focus group interviews. The survey consisted of 11 coding tasks, with varying degrees of ambiguity, purposively sampled from the Norwegian pharmacovigilance registry. Participants selected the appropriate MedDRA® terms and graded the difficulty level of each task on a scale from 1 (least difficult) to 4 (most difficult). Terms selected by participants were compared with a Standard Term Selection (STS), agreed upon by the authors in consultation with a MedDRA® trainer. Inconsistencies with the STS were classified as omission (missing term), substitution (extra term selected in the presence of an omission), and addition (extra term selected and none omitted). In focus groups, participants discussed challenges in the coding tasks and the strategies they used to overcome them. Interview transcripts were analyzed using thematic analysis. RESULTS: In total, 26 coders (79% of the eligible population) completed the survey. Of the survey answers, 36% were identical to the STS; answers consistent with the STS varied across the specific coding tasks and did not align with the perceived difficulty of the tasks. The most common inconsistency (30% of the survey answers) arose from substituting one of multiple MedDRA® terms. Of the survey answers, 18% included omissions without substitutions, and 6% added unnecessary terms to the STS. Eight of the 26 coders (31%) participated in the focus group interviews. Focus group themes revealed that substitutions were explained by difficulties in translating lay language to medical terminology, finding accurate English translations for Norwegian medical terms, and fitting complex descriptions into MedDRA® terms. This was explained by themes related to ambiguity-resolution strategies. Themes explaining omissions included strategies for resolving ambiguity, contextual thinking, causal and pharmacological reasoning in the coding process, and information categorization. CONCLUSIONS: Tailored training programs and clear institutional guidelines are needed to target the sources of coding inconsistencies suggested by this study.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Garmann T, Samdal H, Sartori D, et al. Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers. Drug Saf. 2025. PMID: 40593291. doi:10.1007/s40264-025-01573-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。